These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38444657)

  • 1. Sputum metagenomics of people with bronchiectasis.
    Rosenboom I; Thavarasa A; Richardson H; Long MB; Wiehlmann L; Davenport CF; Shoemark A; Chalmers JD; Tümmler B
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38444657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cystic Fibrosis Upper and Lower Airway Metagenome.
    Pienkowska K; Pust MM; Gessner M; Gaedcke S; Thavarasa A; Rosenboom I; Morán Losada P; Minso R; Arnold C; Hedtfeld S; Dorda M; Wiehlmann L; Mainz JG; Klockgether J; Tümmler B
    Microbiol Spectr; 2023 Mar; 11(2):e0363322. PubMed ID: 36892308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
    Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
    PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria species as pathobionts in bronchiectasis.
    Li L; Mac Aogáin M; Xu T; Jaggi TK; Chan LLY; Qu J; Wei L; Liao S; Cheng HS; Keir HR; Dicker AJ; Tan KS; De Yun W; Koh MS; Ong TH; Lim AYH; Abisheganaden JA; Low TB; Hassan TM; Long X; Wark PAB; Oliver B; Drautz-Moses DI; Schuster SC; Tan NS; Fang M; Chalmers JD; Chotirmall SH
    Cell Host Microbe; 2022 Sep; 30(9):1311-1327.e8. PubMed ID: 36108613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis.
    Narayana JK; Aliberti S; Mac Aogáin M; Jaggi TK; Ali NABM; Ivan FX; Cheng HS; Yip YS; Vos MIG; Low ZS; Lee JXT; Amati F; Gramegna A; Wong SH; Sung JJY; Tan NS; Tsaneva-Atanasova K; Blasi F; Chotirmall SH
    Am J Respir Crit Care Med; 2023 Apr; 207(7):908-920. PubMed ID: 36288294
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered community compositions of
    Guan WJ; Yuan JJ; Li HM; Gao YH; Chen CL; Huang Y; Chen RC; Zhong NS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2173-2182. PubMed ID: 30140149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis.
    Yi XZ; Yang JH; Huang Y; Han XR; Li HM; Cen LJ; Lin ZH; Pan CX; Wang Z; Guan WJ
    Respir Res; 2023 Nov; 24(1):264. PubMed ID: 37919749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum neutrophil elastase associates with microbiota and
    Oriano M; Gramegna A; Terranova L; Sotgiu G; Sulaiman I; Ruggiero L; Saderi L; Wu B; Chalmers JD; Segal LN; Marchisio P; Blasi F; Aliberti S
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32499333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.
    Miao XY; Ji XB; Lu HW; Yang JW; Xu JF
    Chin Med J (Engl); 2015 Oct; 128(20):2792-7. PubMed ID: 26481748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
    Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 18. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P; Jary H; Perry A; Perry JD; Stewart CJ; Nelson A; Lanyon C; Smith DL; Cummings SP; De Soyza A
    BMC Microbiol; 2014 May; 14():130. PubMed ID: 24886473
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Guan WJ; Yuan JJ; Li HM; Gao YH; Huang Y; Chen CL; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1095-1105. PubMed ID: 30092878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.